Clinical Trial Update: Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, immunogenicity, and dose-ranging of an inactivated Zika virus vaccine in healthy participants has completed; results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Flavivirus Infections
• Zika Virus Disease
• Zika Virus Infection

Drugs mentioned

• Inactivated Zika virus vaccine

Snippet

Sponsor: Takeda | Conditions: Virus, Zika, Zika Virus Disease | Phase 1 | Status: COMPLETED | Results posted: 2022-02-11